Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Boron neutron capture therapy (BNCT) selectively destroys human clear cell sarcoma in mouse model.

Fujimoto T, Andoh T, Sudo T, Fujita I, Moritake H, Sugimoto T, Sakuma T, Akisue T, Kawabata S, Kirihata M, Suzuki M, Sakurai Y, Ono K, Fukumori Y, Kurosaka M, Ichikawa H.

Appl Radiat Isot. 2013 Mar;73:96-100. doi: 10.1016/j.apradiso.2012.12.001. Epub 2012 Dec 11.

PMID:
23306161
2.

Boron neutron capture therapy as new treatment for clear cell sarcoma: trial on different animal model.

Andoh T, Fujimoto T, Sudo T, Suzuki M, Sakurai Y, Sakuma T, Moritake H, Sugimoto T, Takeuchi T, Sonobe H, Epstein AL, Fukumori Y, Ono K, Ichikawa H.

Appl Radiat Isot. 2014 Jun;88:59-63. doi: 10.1016/j.apradiso.2013.12.007. Epub 2013 Dec 17.

PMID:
24389062
3.

Boron neutron capture therapy for clear cell sarcoma (CCS): biodistribution study of p-borono-L-phenylalanine in CCS-bearing animal models.

Andoh T, Fujimoto T, Sudo T, Fujita I, Imabori M, Moritake H, Sugimoto T, Sakuma Y, Takeuchi T, Kawabata S, Kirihata M, Akisue T, Yayama K, Kurosaka M, Miyatake S, Fukumori Y, Ichikawa H.

Appl Radiat Isot. 2011 Dec;69(12):1721-4. doi: 10.1016/j.apradiso.2011.02.005. Epub 2011 Mar 1.

PMID:
21367607
4.

Boron neutron capture therapy (BNCT) as a new approach for clear cell sarcoma (CCS) treatment: Trial using a lung metastasis model of CCS.

Andoh T, Fujimoto T, Suzuki M, Sudo T, Sakurai Y, Tanaka H, Fujita I, Fukase N, Moritake H, Sugimoto T, Sakuma T, Sasai H, Kawamoto T, Kirihata M, Fukumori Y, Akisue T, Ono K, Ichikawa H.

Appl Radiat Isot. 2015 Dec;106:195-201. doi: 10.1016/j.apradiso.2015.07.060. Epub 2015 Aug 21.

PMID:
26337135
5.

Evaluation of BPA uptake in clear cell sarcoma (CCS) in vitro and development of an in vivo model of CCS for BNCT studies.

Fujimoto T, Andoh T, Sudo T, Fujita I, Imabori M, Moritake H, Sugimoto T, Sakuma Y, Takeuchi T, Sonobe H, Epstein AL, Akisue T, Kirihata M, Kurosaka M, Fukumori Y, Ichikawa H.

Appl Radiat Isot. 2011 Dec;69(12):1713-6. doi: 10.1016/j.apradiso.2011.02.006. Epub 2011 Feb 12.

PMID:
21354804
6.

Potential of boron neutron capture therapy (BNCT) for malignant peripheral nerve sheath tumors (MPNST).

Fujimoto T, Andoh T, Sudo T, Fujita I, Fukase N, Takeuchi T, Sonobe H, Inoue M, Hirose T, Sakuma T, Moritake H, Sugimoto T, Kawamoto T, Fukumori Y, Yamamoto S, Atagi S, Sakurai Y, Kurosaka M, Ono K, Ichikawa H, Suzuki M.

Appl Radiat Isot. 2015 Dec;106:220-5. doi: 10.1016/j.apradiso.2015.07.059. Epub 2015 Aug 3.

PMID:
26278348
7.

Boron neutron capture therapy of brain tumors: enhanced survival and cure following blood-brain barrier disruption and intracarotid injection of sodium borocaptate and boronophenylalanine.

Barth RF, Yang W, Rotaru JH, Moeschberger ML, Boesel CP, Soloway AH, Joel DD, Nawrocky MM, Ono K, Goodman JH.

Int J Radiat Oncol Biol Phys. 2000 Apr 1;47(1):209-18.

PMID:
10758326
8.

Delivery of (10)boron to oral squamous cell carcinoma using boronophenylalanine and borocaptate sodium for boron neutron capture therapy.

Obayashi S, Kato I, Ono K, Masunaga S, Suzuki M, Nagata K, Sakurai Y, Yura Y.

Oral Oncol. 2004 May;40(5):474-82.

PMID:
15006618
9.

Boron neutron capture therapy induces apoptosis of glioma cells through Bcl-2/Bax.

Wang P, Zhen H, Jiang X, Zhang W, Cheng X, Guo G, Mao X, Zhang X.

BMC Cancer. 2010 Dec 2;10:661. doi: 10.1186/1471-2407-10-661.

10.

Intracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT).

Maruyama K, Ishida O, Kasaoka S, Takizawa T, Utoguchi N, Shinohara A, Chiba M, Kobayashi H, Eriguchi M, Yanagie H.

J Control Release. 2004 Aug 11;98(2):195-207.

PMID:
15262412
11.

Optimization of boron neutron capture therapy for the treatment of undifferentiated thyroid cancer.

Dagrosa MA, Thomasz L, Longhino J, Perona M, Calzetta O, Blaumann H, Rebagliati RJ, Cabrini R, Kahl S, Juvenal GJ, Pisarev MA.

Int J Radiat Oncol Biol Phys. 2007 Nov 15;69(4):1059-66.

PMID:
17967301
12.

Biodistribution of boron compounds in an animal model of human undifferentiated thyroid cancer for boron neutron capture therapy.

Dagrosa MA, Viaggi M, Rebagliati RJ, Batistoni D, Kahl SB, Juvenal GJ, Pisarev MA.

Mol Pharm. 2005 Mar-Apr;2(2):151-6.

PMID:
15804189
13.

Combination of the vascular targeting agent ZD6126 with boron neutron capture therapy.

Masunaga S, Sakurai Y, Suzuki M, Nagata K, Maruhashi A, Kinash Y, Ono K.

Int J Radiat Oncol Biol Phys. 2004 Nov 1;60(3):920-7.

PMID:
15465210
14.

Effects of boron neutron capture therapy on human oral squamous cell carcinoma in a nude mouse model.

Kamida A, Obayashi S, Kato I, Ono K, Suzuki M, Nagata K, Sakurai Y, Yura Y.

Int J Radiat Biol. 2006 Jan;82(1):21-9.

PMID:
16546900
15.

Neutron capture therapy of the 9L rat gliosarcoma using the p-boronophenylalanine-fructose complex.

Coderre JA, Button TM, Micca PL, Fisher CD, Nawrocky MM, Liu HB.

Int J Radiat Oncol Biol Phys. 1994 Oct 15;30(3):643-52.

PMID:
7928496
16.

Enhanced survival of glioma bearing rats following boron neutron capture therapy with blood-brain barrier disruption and intracarotid injection of boronophenylalanine.

Yang W, Barth RF, Rotaru JH, Moeschberger ML, Joel DD, Nawrocky MM, Goodman JH.

J Neurooncol. 1997 May;33(1-2):59-70.

PMID:
9151224
17.

Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of sodium borocaptate with or without blood-brain barrier disruption.

Yang W, Barth RF, Rotaru JH, Moeschberger ML, Joel DD, Nawrocky MM, Goodman JH, Soloway AH.

Int J Radiat Oncol Biol Phys. 1997 Feb 1;37(3):663-72.

PMID:
9112465
18.

Combination of boron neutron capture therapy and external beam radiotherapy for brain tumors.

Barth RF, Grecula JC, Yang W, Rotaru JH, Nawrocky M, Gupta N, Albertson BJ, Ferketich AK, Moeschberger ML, Coderre JA, Rofstad EK.

Int J Radiat Oncol Biol Phys. 2004 Jan 1;58(1):267-77.

PMID:
14697448
19.

Application of boron-entrapped stealth liposomes to inhibition of growth of tumour cells in the in vivo boron neutron-capture therapy model.

Yanagie H, Maruyama K, Takizawa T, Ishida O, Ogura K, Matsumoto T, Sakurai Y, Kobayashi T, Shinohara A, Rant J, Skvarc J, Ilic R, Kuhne G, Chiba M, Furuya Y, Sugiyama H, Hisa T, Ono K, Kobayashi H, Eriguchi M.

Biomed Pharmacother. 2006 Jan;60(1):43-50. Epub 2005 Sep 21.

PMID:
16260113
20.

Cationized gelatin-HVJ envelope with sodium borocaptate improved the BNCT efficacy for liver tumors in vivo.

Fujii H, Matsuyama A, Komoda H, Sasai M, Suzuki M, Asano T, Doki Y, Kirihata M, Ono K, Tabata Y, Kaneda Y, Sawa Y, Lee CM.

Radiat Oncol. 2011 Jan 20;6:8. doi: 10.1186/1748-717X-6-8.

Supplemental Content

Support Center